Islatravir
id:
islatravir-308-8952992
title:
Islatravir
text:
Islatravir is an investigational drug for the treatment of HIV infection. It is classified as a nucleoside reverse transcriptase translocation inhibitor (NRTTI). Merck is developing a subdermal drug-eluting implant to administer islatravir. In 2021, FDA placed a partial clinical hold for several studies under Islatravir. The reason was a decline in CD4 T cells under therapy. Merck announced to restart the study program in 2023 with a decreased dose, however studies of islatravir for pre-exposure
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Islatravir
date created:
date modified:
2024-03-10T17:09:51Z
main entity:
{"identifier":"Q24977417","url":"https://www.wikidata.org/entity/Q24977417"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/49/Islatravir_structure.svg","width":512,"height":420}
fields total:
13
integrity:
15